US OptionsDetailed Quotes
RIGL241220P21000
- 2.15
- 0.000.00%
15min DelayTrading Dec 13 14:39 ET
0.00High0.00Low
0.00Open2.15Pre Close0 Volume33 Open Interest21.00Strike Price0.00Turnover77.31%IV1.67%PremiumDec 20, 2024Expiry Date1.83Intrinsic Value100Multiplier4DDays to Expiry0.32Extrinsic Value100Contract SizeAmericanOptions Type-0.8698Delta0.1375Gamma9.71Leverage Ratio-0.0373Theta-0.0017Rho-8.44Eff Leverage0.0043Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet